In acute myeloid leukemia (AML), knocking down let‐7b in TAMs repolarizes leukemia‐associated macrophages toward an M1‐like phenotype via activation of the Toll‐like receptor and NF‐κB pathways, thereby inhibiting AML progression [40]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.